The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/37245
StudyName: Eligibility Stage IV or Recurrent Non-Small Cell Lung Cancer NCT02041533
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 11.07.2019
License: Creative Commons BY 4.0

----

Description: 
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026); ODM derived from: https://clinicaltrials.gov/show/NCT02041533
